KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Goodwill (2016 - 2025)

Idexx Laboratories has reported Goodwill over the past 17 years, most recently at $414.0 million for Q4 2025.

  • Quarterly results put Goodwill at $414.0 million for Q4 2025, up 2.2% from a year ago — trailing twelve months through Dec 2025 was $414.0 million (up 2.2% YoY), and the annual figure for FY2025 was $414.0 million, up 2.2%.
  • Goodwill for Q4 2025 was $414.0 million at Idexx Laboratories, roughly flat from $413.7 million in the prior quarter.
  • Over the last five years, Goodwill for IDXX hit a ceiling of $414.5 million in Q2 2025 and a floor of $1.8 million in Q1 2021.
  • Median Goodwill over the past 5 years was $362.4 million (2023), compared with a mean of $276.5 million.
  • Biggest five-year swings in Goodwill: plummeted 98.45% in 2021 and later skyrocketed 19953.78% in 2022.
  • Idexx Laboratories' Goodwill stood at $359.3 million in 2021, then tumbled by 95.02% to $17.9 million in 2022, then soared by 1944.81% to $366.0 million in 2023, then grew by 10.68% to $405.1 million in 2024, then grew by 2.2% to $414.0 million in 2025.
  • The last three reported values for Goodwill were $414.0 million (Q4 2025), $413.7 million (Q3 2025), and $414.5 million (Q2 2025) per Business Quant data.